Pharmaceuticals
sme
Bidding period
Bid price
Listing on
Listing date
Lot size
Issue size
Minimum investment
Maximum investment
Bidding closed on 25 May 2026
Particulars |
For the period ending in March 2025 (in ₹ million) |
|---|---|
| Total assets | ₹39.12 |
| Total liabilities | ₹39.12 |
| Total expenditure | ₹25.18 |
| Total revenue | ₹38.33 |
| Profit after tax | ₹9.79 |
| EBITDA | ₹15.34 |
| Adjusted EBITDA | ₹0.00 |
| Total assets | ₹19.53 |
| Total liabilities | ₹19.53 |
| Total expenditure | ₹11.69 |
| Total revenue | ₹15.34 |
| Profit after tax | ₹2.50 |
| EBITDA | ₹5.73 |
| Adjusted EBITDA | ₹0.00 |
| Total assets | ₹17.57 |
| Total liabilities | ₹17.57 |
| Total expenditure | ₹15.80 |
| Total revenue | ₹16.25 |
| Profit after tax | ₹0.33 |
| EBITDA | ₹1.72 |
| Adjusted EBITDA | ₹0.00 |
| Pre-issue | Post-issue | |
|---|---|---|
| Promoter group | 96.84 | 67.69 |
| Public group | 3.16 | 32.31 |
Designing and execution capabilities.
Experienced management team and a motivated and efficient work force.
Cordial relations with our consumers.
Quality assurance and control.
Skyline Financial Services Pvt |
|
|---|---|
| Phone number | +91-11-40450193-97 |
| E-mail ID | ipo@skylinerta.com |
| Website | www.skylinerta.com |
QIB shares offered |
36,000 (0.95%) |
NII (HNI) shares offered |
17,55,000 (46.53%) |
Retail shares offered |
17,92,000 (47.51%) |
Anchor investor shares offered |
0 (0.0%) |
Total shares offered |
37,72,000 |
Total shares with anchor investor |
37,72,000 |
Bidding period
To Be AnnouncedBid price range
To Be AnnouncedBidding period
To Be AnnouncedBid price range
To Be AnnouncedBidding period
To Be AnnouncedBid price range
To Be AnnouncedBidding period
To Be AnnouncedBid price range
To Be AnnouncedBidding period
To Be AnnouncedBid price range
To Be Announced
The listing date for the Bio Medica Laboratories Ltd IPO is 29 May 2026.
The issue size of the Bio Medica Laboratories Ltd IPO is ₹52.43 cr.
The minimum lot size for Bio Medica Laboratories Ltd IPO is 1000
Bio Medica Laboratories Ltd IPO is open from 21 May 2026 to 25 May 2026.
To apply for the Bio Medica Laboratories Ltd, follow the steps given below:
Primary market vs. Secondary market
Things to consider before investing in IPO
What are IPOs?
What is the meaning of listing date for an IPO?
*Disclaimer for Bajaj Finance Limited (‘BFL’):
Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.
When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.
BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."
**Disclaimer: For Bajaj Financial Securities Limited
Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.
Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.
Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.
Powered by Bajaj Financial Securities Limited (Bajaj Broking)
